Drug Target Review company information, Employees & Contact Information

New gene therapy restores brain function in SYNGAP1 disorder Drug Target Review

New AI method maps how tuberculosis drugs destroy bacteria Drug Target Review

c-Kit helps sweet cells survive and regenerate taste Drug Target Review

How medications in waterways are encouraging antibiotic resistance Drug Target Review

Targeting EZH2 may prevent triple-negative breast cancer spread Drug Target Review

Blocking SLAMF6 enables T cells to kill leukaemia cells Drug Target Review

Pemafibrate and telmisartan combo may reverse fatty liver Drug Target Review

Beyond the hype: a veteran’s honest assessment of AI in drug discovery – Part 2 Drug Target Review

New drug combination shows potential to treat enteroviruses Drug Target Review

LINC01235 identified as driver of aggressive breast cancer Drug Target Review

Bacteria-boosted nanoparticles offer a triple threat against cancer Drug Target Review

Animal-free drug discovery is closer with QSP Drug Target Review

AI at the forefront of age-related disease treatment Drug Target Review

Beyond the Lab: Clinical Trials Drug Target Review

From siloed data to breakthroughs: multimodal AI in drug discovery Drug Target Review

New nanoparticle enhances cancer drug penetration Drug Target Review

Next-gen ADCs: Tubulis sets new standard in cancer treatment Drug Target Review

Deep-sea sugar EPS3.9 sparks immune attack on tumours Drug Target Review

From injections to pills: oral peptides set to transform drug development Drug Target Review

AI meets human tissue to fast-track precision medicine development Drug Target Review

First AI-designed drug, Rentosertib, officially named by USAN Drug Target Review

Turning AI into a biological design engine Drug Target Review

Kidney tumour organoids offer new drug testing platform Drug Target Review

ecDNA discovery targets ‘zombie’ cells in childhood cancers Drug Target Review

Targeting PLA2G15 to treat neurometabolic disorders Drug Target Review

New CRISPR breakthrough could transform sickle cell treatment Drug Target Review

Allele-selective gene editing: a breakthrough in Huntington’s disease treatment Drug Target Review

Fixing drug discovery’s most persistent problem with AI Drug Target Review

Early evidence and emerging trends: How AI is shaping drug discovery and clinical development Drug Target Review

Lithium deficiency identified as key Alzheimer’s trigger Drug Target Review

Chikungunya’s 2025 surge sparks urgent research response Drug Target Review

New genetic discovery offers hope for arthritis drug development Drug Target Review

Study aims to stop Alzheimer’s with stem cell infusions Drug Target Review

New data backs Myo4 for obesity treatment Drug Target Review

Diabetes drug found to protect heart during cancer treatment Drug Target Review

Astrocyte protein RTP801 linked to Alzheimer’s cognitive decline Drug Target Review

Cilta-cel: A new era in multiple myeloma treatment Drug Target Review

AI platform detects new drug targets in minutes Drug Target Review

Navigating the AI revolution: a roadmap for pharma’s future Drug Target Review

Promising psoriasis treatment reduces symptoms without steroids Drug Target Review

FORESIGHT consortium secures €9 million to fast-track drug development Drug Target Review

New 3D bioprinted lung tissue could transform respiratory research Drug Target Review

New research offers hope for high-grade glioma treatment Drug Target Review

ABB’s robotics ecosystem: advancing lab efficiency in drug discovery Drug Target Review

Using clinical genomics and AI in drug development to elevate success Drug Target Review

Beyond the Lab: Stem cell research Drug Target Review

Scientists turn superbug MRSA into treatable infection Drug Target Review

CNIC identifies key mechanism in fat cells to combat obesity Drug Target Review

Radiotracer targets key cancer biomarker for precision treatment Drug Target Review

Study reveals how neurotransmitters influence brain gene expression Drug Target Review

Obstacles and innovations of macrocyclic drug development Drug Target Review

Boltz-1: A new open-source AI tool for drug discovery Drug Target Review

New DNA nanostructures set to transform cancer treatment Drug Target Review

New targeted therapies show promise in lung cancer treatment Drug Target Review

Breakthrough trial offers new hope for cystic fibrosis patients Drug Target Review

Beyond ELISA: the future of biomarker validation Drug Target Review

Issue 4 2023 Drug Target Review

Artificial intelligence-aided screening could boost speed of new drug discovery Drug Target Review

Using genetics to identify drug targets for fibrotic lung diseases Drug Target Review

Dynamic molecular aggregates within cells Drug Target Review

New potential drug target is discovered for diabetes treatment Drug Target Review

Optimising CRISPR gene editing of hard-to-transfect cells Drug Target Review

The future of drug development: AI tailors artificial DNA Drug Target Review

The role of anti-viral drug development in a new pandemic era Drug Target Review

Peptides: a promising alternative to opioids for chronic pain relief Drug Target Review

Discovering and designing drugs with artificial intelligence Drug Target Review

3D bioprinting artificial organs could become quicker and easier Drug Target Review

Immune cell populations have been mapped to provide new insights into how the immune system works Drug Target Review

Researchers develop drug discovery tool for RNA Drug Target Review

Aptamer inhibits SARS-CoV-2 with novel mechanism of action, study shows Drug Target Review

Leveraging ADCs in precision oncology strategy Drug Target Review

Navigating the challenges of cell therapies Drug Target Review

Alzheimer’s disease: driving advancements with precision medicine Drug Target Review

How do fast-growing bacteria resist antibiotics? Drug Target Review

Five recent cell and gene therapy discoveries Drug Target Review

Role of retrons in bacteria revealed, with potential for use in gene editing Drug Target Review

CRISPR activation: quicker diagnosis of rare genetic diseases Drug Target Review

Decoding stem cells for personalised regenerative medicine Drug Target Review

Scientists test new anti-PD-L1 cancer vaccine against melanoma Drug Target Review

Researchers have engineered AAV vectors that cross the blood-brain barrier Drug Target Review

AI & Informatics: Drug discovery and development – industry survey infographic Drug Target Review

Adapting drug discovery to Artificial Intelligence Drug Target Review

Antibody Drug Conjugates: windows of opportunity Drug Target Review

Drug discovery for COPD treatments Drug Target Review

Developing an mRNA therapy for Duchenne muscular dystrophy Drug Target Review

New insight to guide discovery of drugs targeting ion channels Drug Target Review

Advancing cell therapies with engineered Tregs Drug Target Review

Using big data approaches to develop cell therapies Drug Target Review

Unique method to find cancer mutations offers chance of improved treatment Drug Target Review

Researchers identify potential enterovirus drug target Drug Target Review

A new 3D tool for measuring intracellular lipid droplets Drug Target Review

Microscopy reveals four classes of SARS-CoV-2 neutralising antibodies Drug Target Review

Promising targets for deafness drug discovery Drug Target Review

Study shows structure of biocatalysts changes in certain environments Drug Target Review

Pathways in COVID-19 replication and pre-clinical drug target identification Drug Target Review

Gangliosides enable hepatitis A to infect hepatocytes Drug Target Review

Miniaturising organoid drug screens using nanofibrillar cellulose hydrogels Drug Target Review

Eliminating the HIV virus from infected cells with CRISPR-Cas Drug Target Review

Novel bronchodilator could be used for control of asthma Drug Target Review

Machine learning reveals potential COVID-19 therapeutic compounds Drug Target Review